➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Mallinckrodt
Dow
Merck
Moodys

Last Updated: September 16, 2021

DrugPatentWatch Database Preview

Glucagon hydrochloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic sources for glucagon hydrochloride and what is the scope of patent protection?

Glucagon hydrochloride is the generic ingredient in two branded drugs marketed by Novo Nordisk, Lilly, and Fresenius Kabi Usa, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for glucagon hydrochloride. Four suppliers are listed for this compound.

Summary for glucagon hydrochloride
US Patents:0
Tradenames:2
Applicants:3
NDAs:3
Drug Master File Entries: 12
Finished Product Suppliers / Packagers: 4
Clinical Trials: 721
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in glucagon hydrochloride?glucagon hydrochloride excipients list
DailyMed Link:glucagon hydrochloride at DailyMed
Recent Clinical Trials for glucagon hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of MinnesotaPhase 2
Peking Union Medical College HospitalEarly Phase 1
University Medical Center GroningenPhase 3

See all glucagon hydrochloride clinical trials

US Patents and Regulatory Information for glucagon hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa GLUCAGON glucagon hydrochloride POWDER;INTRAMUSCULAR, INTRAVENOUS 201849-001 May 8, 2015 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Lilly GLUCAGON glucagon hydrochloride INJECTABLE;INJECTION 012122-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Lilly GLUCAGON glucagon hydrochloride INJECTABLE;INJECTION 012122-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Novo Nordisk GLUCAGEN glucagon hydrochloride INJECTABLE;INJECTION 020918-001 Jun 22, 1998 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Mallinckrodt
Dow
Merck
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.